Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Imunon, Inc. Director's Dealing 2012

Feb 24, 2012

35124_dirs_2012-02-24_a0d7aa49-27bd-4a9d-b274-87f2527cb7c6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-02-22

Reporting Person: LINK MAX (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-22 Option to purchase Celsion Corporation Common Stock $2.06 A 35000 Acquired 2022-02-22 Celsion Corporation Common Stock (35000) Direct

Footnotes

F1: The options vest in thirds over three years on the anniversary date of the option grant.